Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
NetSol Technologies
NTWK
$49.3M
| $1.21M | ﹤0.01% |
305,300
-5,420
| -2% | -$24.1K |
|
|
ZEUS
2502
DELISTED
Olympic Steel
ZEUS
| $1.21M | ﹤0.01% |
61,900
-104,500
| -63% | -$1.91M |
|
2503
Patrick Industries
PATK
$2.79B
| $1.2M | ﹤0.01% |
37,127
-113,175
| -75% | -$3.52M |
|
|
CTB
2504
DELISTED
Cooper Tire & Rubber Co.
CTB
| $1.2M | ﹤0.01% |
33,200
-453,900
| -93% | -$17.5M |
|
2505
iShares China Large-Cap ETF
FXI
$4.16B
| $1.2M | ﹤0.01% |
30,100
-53,100
| -64% | -$2.08M |
|
|
STZ.B
2506
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.19M | ﹤0.01% |
6,100
+200
| +3% | +$35.8K |
|
2507
RF Industries
RFIL
$144M
| $1.19M | ﹤0.01% |
657,100
-2,200
| -0.3% | -$3.55K |
|
|
CAW
2508
DELISTED
CCA Industries, Inc.
CAW
| $1.18M | ﹤0.01% |
345,600
+4,500
| +1% | +$14.6K |
|
2509
Emerson Radio
MSN
$7.99M
| $1.17M | ﹤0.01% |
844,100
+2,700
| +0.3% | +$3.51K |
|
|
MRIN
2510
DELISTED
Marin Software
MRIN
| $1.17M | ﹤0.01% |
21,452
+1,697
| +9% | +$107K |
|
|
WG
2511
DELISTED
Willbros Group
WG
| $1.16M | ﹤0.01% |
469,900
-79,300
| -14% | -$202K |
|
|
MSBF
2512
DELISTED
MSB Financial Corp.
MSBF
| $1.16M | ﹤0.01% |
66,500
+8,500
| +15% | +$146K |
|
2513
First US Bancshares
FUSB
$90.6M
| $1.15M | ﹤0.01% |
102,500
-1,700
| -2% | -$19.8K |
|
2514
FB Financial Corp
FBK
$3.1B
| $1.15M | ﹤0.01% |
31,700
+11,100
| +54% | +$399K |
|
|
HOME
2515
DELISTED
At Home Group Inc.
HOME
| $1.15M | ﹤0.01% |
49,200
+32,600
| +196% | +$617K |
|
|
MRVC
2516
DELISTED
MRV Communications Inc
MRVC
| $1.14M | ﹤0.01% |
115,900
| – | – |
|
2517
Iridium Communications
IRDM
$5.27B
| $1.14M | ﹤0.01% |
+103,099
| New | +$1.08M |
|
|
LABL
2518
DELISTED
Multi-Color Corp
LABL
| $1.13M | ﹤0.01% |
+13,900
| New | +$1.1M |
|
|
BLDP
2519
Ballard Power Systems
BLDP
$790M
| $1.13M | ﹤0.01% |
389,500
+223,900
| +135% | +$630K |
|
2520
Lantronix
LTRX
$272M
| $1.13M | ﹤0.01% |
464,966
+3,657
| +0.8% | +$10K |
|
2521
AMCON Distributing
DIT
$66.4M
| $1.13M | ﹤0.01% |
16,050
| – | – |
|
2522
Ambarella
AMBA
$3.6B
| $1.13M | ﹤0.01% |
23,200
-70,300
| -75% | -$3.89M |
|
|
WES
2523
DELISTED
Western Gas Partners Lp
WES
| $1.12M | ﹤0.01% |
+20,090
| New | +$1.14M |
|
2524
Enel Chile
ENIC
$6.05B
| $1.12M | ﹤0.01% |
204,204
+39,004
| +24% | +$216K |
|
|
FCCY
2525
DELISTED
1st Constitution Bancorp
FCCY
| $1.11M | ﹤0.01% |
63,200
-2,300
| -4% | -$40.4K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.